On Friday, Novartis AG (NYSE:NVS) shared final results from the Phase 3 ALIGN study supporting a slowing decline in kidney...
shows
Credit: CC0 Public Domain It can be challenging to identify which patients with advanced chronic kidney disease (CKD) will most...
Over two-thirds (68%) of people without diabetes or prediabetes have never considered their type 2 diabetes risk, a survey by...
Medicare beneficiaries who also receive Medicaid — known as dual eligibles — make up one-sixth of the traditional Medicare population...
An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate...
Using cutting-edge breath sampling, scientists have achieved a breakthrough in diagnosing lower respiratory tract infections with an in vitro assay...
